Tag Archives : kleiner perkins caufield

Some VCs are getting an early Valentine’s Day gift fromTheFunded, the site where CEOs rate venture capitalists and their firms. Below you will find the top-ranked individual VCs, as determined by their ratings in 2009. What makes this ranking particularly useful to entrepreneurs is that it is ratings by other CEOs, often CEOs who have had direct dealings with the VCs they are rating. While [...]

Since 1990, FloDesign has been making aerospace and jet propulsion equipment. It is now bringing this experience to the design and manufacture of wind turbines under the banner of FloDesign Wind Turbine, and has raised $34.5 million (PDF) to do make its novel idea a reality. The news is significant for two reasons. First, it has recruited a top-tier crop of investors, including Kleiner Perkins Caufield [...]

iPhone application development firm Shopkick has raised $2.5 million in a first round of venture capital, according to a filing with the SEC. Based in Menlo Park, Calif., the company is best known for an app called CauseWorld. Users can earn points by shopping or even just checking in (like on Foursquare) at brand retailers — points that they can convert into charitable donations to causes of [...]

Game investing is still going strong, even though it did take a hit during the recession. We calculated that game companies raised $600.5 million in 2009, down 36 percent from the year before. But game-savvy venture capitalists are still bullish on games. We did a roundtable Q&A with some of the best-known investors, in conjunction with the launch of Interactive Age, a new magazine focused on the [...]

ReputationDefender, provider of tools that allow people to manage and monitor what is being published about them on the internet, has raised $8.7 million in a second round of funding, according to a filing with the SEC. Based in Redwood City, Calif., the company is backed by Bessemer Venture Partners, Kleiner Perkins Caufield & Byers and Maples Investments.

Nodality, developer of diagnostics used to identify bloodstream malignancies and autoimmune disorders, has brought in $10 million of a $13.5 million round of equity. Based in South San Francisco, the company is backed by Kleiner Perkins Caufield & Byers, Maverick Capital and TPG Biotechnology.